PERSON & COVEY, INC. – Trademark Portfolio
Entity Type: 03
PERSON & COVEY, INC. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include DHS, DML, XERAC, DRYSOL, and SOLBAR. The owner is based in GLENDALE, CA.
236 S. VERDUGO ROAD
GLENDALE, CA
Showing of trademarks Trademarks
Trademark Classifications
PERSON & COVEY, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does PERSON & COVEY, INC. have?
PERSON & COVEY, INC. has 18 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 abandoned, 9 cancelled.
What trademark classes does PERSON & COVEY, INC. file in?
PERSON & COVEY, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PERSON & COVEY, INC.'s most well-known trademarks?
PERSON & COVEY, INC.'s registered trademark portfolio includes well-known marks such as DHS, DML, XERAC, DRYSOL, and SOLBAR. These are among 8 currently registered trademarks in the portfolio.
What is PERSON & COVEY, INC.'s trademark registration success rate?
PERSON & COVEY, INC. has a 44% trademark registration rate, with 8 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.